Lexatumumab, a engineered antibody, represents remarkable promise in the treatment against cancer disease. This new drug uniquely targets to the HER3 protein, which are frequently elevated in various tumoral forms. https://dirstop.com/story28422343/lexatumumab-a-promising-approach-for-tumors